BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 23189187)

  • 1. Inhibition of PTEN gene expression by oncogenic miR-23b-3p in renal cancer.
    Zaman MS; Thamminana S; Shahryari V; Chiyomaru T; Deng G; Saini S; Majid S; Fukuhara S; Chang I; Arora S; Hirata H; Ueno K; Singh K; Tanaka Y; Dahiya R
    PLoS One; 2012; 7(11):e50203. PubMed ID: 23189187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-129-3p, as a diagnostic and prognostic biomarker for renal cell carcinoma, attenuates cell migration and invasion via downregulating multiple metastasis-related genes.
    Chen X; Ruan A; Wang X; Han W; Wang R; Lou N; Ruan H; Qiu B; Yang H; Zhang X
    J Cancer Res Clin Oncol; 2014 Aug; 140(8):1295-304. PubMed ID: 24802708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased miR-200a-3p is a key regulator of renal carcinoma growth and migration by directly targeting CBL.
    Ding M; Sun X; Zhong J; Zhang C; Tian Y; Ge J; Zhang CY; Zen K; Wang JJ; Zhang C; Wang C
    J Cell Biochem; 2018 Dec; 119(12):9974-9985. PubMed ID: 30171729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-130b Promotes Sunitinib Resistance through Regulation of PTEN in Renal Cell Carcinoma.
    Sekino Y; Sakamoto N; Sentani K; Oue N; Teishima J; Matsubara A; Yasui W
    Oncology; 2019; 97(3):164-172. PubMed ID: 31195398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-200a-3p suppresses tumor proliferation and induces apoptosis by targeting SPAG9 in renal cell carcinoma.
    Wang X; Jiang F; Song H; Li X; Xian J; Gu X
    Biochem Biophys Res Commun; 2016 Feb; 470(3):620-626. PubMed ID: 26797273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-144-3p serves as a tumor suppressor for renal cell carcinoma and inhibits its invasion and metastasis by targeting MAP3K8.
    Liu F; Chen N; Xiao R; Wang W; Pan Z
    Biochem Biophys Res Commun; 2016 Nov; 480(1):87-93. PubMed ID: 27717821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An increased level of MiR-222-3p is associated with TMP2 suppression, ERK activation and is associated with metastasis and a poor prognosis in renal clear cell carcinoma.
    Lyu J; Zhu Y; Zhang Q
    Cancer Biomark; 2020; 28(2):141-149. PubMed ID: 32116235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CircRNA cRAPGEF5 inhibits the growth and metastasis of renal cell carcinoma via the miR-27a-3p/TXNIP pathway.
    Chen Q; Liu T; Bao Y; Zhao T; Wang J; Wang H; Wang A; Gan X; Wu Z; Wang L
    Cancer Lett; 2020 Jan; 469():68-77. PubMed ID: 31629934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of miR-193a-3p inhibits cell growth and migration in renal cell carcinoma by targeting PTEN.
    Liu L; Li Y; Liu S; Duan Q; Chen L; Wu T; Qian H; Yang S; Xin D
    Tumour Biol; 2017 Jun; 39(6):1010428317711951. PubMed ID: 28639901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA-21 governs TORC1 activation in renal cancer cell proliferation and invasion.
    Dey N; Das F; Ghosh-Choudhury N; Mandal CC; Parekh DJ; Block K; Kasinath BS; Abboud HE; Choudhury GG
    PLoS One; 2012; 7(6):e37366. PubMed ID: 22685542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal microRNA-23b-3p promotes tumor angiogenesis and metastasis by targeting PTEN in salivary adenoid cystic carcinoma.
    Hou CX; Sun NN; Han W; Meng Y; Wang CX; Zhu QH; Tang YT; Ye JH
    Carcinogenesis; 2022 Aug; 43(7):682-692. PubMed ID: 35380635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
    Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
    EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-302c-3p inhibits renal cell carcinoma cell proliferation by targeting Grb2-associated binding 2 (Gab2).
    Gu DH; Mao JH; Pan XD; Zhu H; Chen X; Zheng B; Shan Y
    Oncotarget; 2017 Apr; 8(16):26334-26343. PubMed ID: 28412750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ciRS-7 is a prognostic biomarker and potential gene therapy target for renal cell carcinoma.
    Mao W; Wang K; Xu B; Zhang H; Sun S; Hu Q; Zhang L; Liu C; Chen S; Wu J; Chen M; Li W; Peng B
    Mol Cancer; 2021 Nov; 20(1):142. PubMed ID: 34740354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
    Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
    Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
    Yamasaki T; Seki N; Yoshino H; Itesako T; Hidaka H; Yamada Y; Tatarano S; Yonezawa T; Kinoshita T; Nakagawa M; Enokida H
    J Urol; 2013 Sep; 190(3):1059-68. PubMed ID: 23454155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genistein downregulates onco-miR-1260b and inhibits Wnt-signalling in renal cancer cells.
    Hirata H; Ueno K; Nakajima K; Tabatabai ZL; Hinoda Y; Ishii N; Dahiya R
    Br J Cancer; 2013 May; 108(10):2070-8. PubMed ID: 23591200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-23b-3p acts as a counter-response against skeletal muscle atrophy.
    Okamura T; Hashimoto Y; Osaka T; Senmaru T; Fukuda T; Hamaguchi M; Fukui M
    J Endocrinol; 2020 Mar; 244(3):535-547. PubMed ID: 31958315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma.
    Liep J; Kilic E; Meyer HA; Busch J; Jung K; Rabien A
    PLoS One; 2016; 11(6):e0157801. PubMed ID: 27336447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-509-3p inhibits cancer cell proliferation and migration by targeting the mitogen-activated protein kinase kinase kinase 8 oncogene in renal cell carcinoma.
    Su Z; Chen D; Zhang E; Li Y; Yu Z; Shi M; Jiang Z; Ni L; Yang S; Gui Y; Ye J; Lai Y
    Mol Med Rep; 2015 Jul; 12(1):1535-43. PubMed ID: 25815776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.